Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis

Clinical trial NCT06137651 · WITHDRAWN

Trial details

NCT number: NCT06137651
Sponsor: Northwestern University
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Carcinoma Metastatic Malignant Neoplasm in the Brain Metastatic Malignant Neoplasm in the Leptomeninges

Start date: 2023-12-31
Primary completion: 2024-03-27
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.